首页> 外文期刊>Clinical Chemistry >Validity of Maternal Genotypes in DNA from Archival Pregnancy Serum Samples
【24h】

Validity of Maternal Genotypes in DNA from Archival Pregnancy Serum Samples

机译:档案孕妇血清样本中DNA的母本基因型的有效性。

获取原文
获取原文并翻译 | 示例
           

摘要

The large populationbased serum biobanks collected for maternal (pregnancy) screening and stored in many countries could be useful for genetic epidemiologic studies if DNA extracted from archival serum and plasma is of sufficient quantity and quality for successful genotyping analyses (2-4). The presence of realistic amounts of fetal DNA of a discordant genotype may at worst cause an indeterminate genotypic assignment but will not cause false maternal genotyping results on the TaqMan 7900 HT system.MDA is not recommended on DNA extracted from serum samples.
机译:如果从档案血清和血浆中提取的DNA具有足够的数量和质量,可以成功进行基因分型分析,则收集用于母亲(妊娠)筛查并存储在许多国家中的大量基于人口的血清生物库可能对遗传流行病学研究有用(2-4)。实际存在的基因型不一致的胎儿DNA在最坏的情况下可能会导致不确定的基因型分配,但不会在TaqMan 7900 HT系统上造成错误的母体基因分型结果。不建议在从血清样品中提取的DNA上使用MDA。

著录项

  • 来源
    《Clinical Chemistry》 |2009年第4期|p.842-843|共2页
  • 作者单位

    Author Contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following 3 requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data, (b) drafting or revising the article for intellectual content, and (c) final approval of the published article.Authors' Disclosures of Potential Conflicts of Interest: Upon manuscript submission, all authors completed the Disclosures of Potential Conflict of Interest form. Potential conflicts of interest:Employment or Leadership: None declared.Consultant or Advisory Role: J.A. Carlson, Qiagen.Stock Ownership: None declared.Honoraria: None declared.Research Funding: This study was supported by the Swedish National Biobanking Program, financed by the Knut and Alice Wallenberg Foundation functional genomics initiatives Swegene andWCNand by the EU 6th framework grant Cancer Control using Population-based Registries and Biobanks (principal investigator, J. Dillner).Expert Testimony: J.A. Carlson has presented her laboratory's production data at two lectures for Qiagen without economic remuneration.Role of Sponsor: The funding organizations played no role in the design of study, choice of enrolled patients, review and interpretation of data, or preparation or approval of manuscript.Acknowledgments: We thank Maria Anderberg, Kia Sjölin, Aline Marshall, Kristin Andersson, Christina Gerouda, and Sophia Harlid for excellent laboratory assistance.Malin I. L. Ivarsson2,3,4*Joakim Dillner2,4Joyce Carlson2,32 The Swedish National Biobanking Program and Departments of 3 Clinical Chemistry and 4 Medical MicrobiologyLund UniversityMalmö University HospitalMalmö, Sweden*Address correspondence to this author at:Department of Clinical ChemistryUniversity Hospital MAS, Entrance 71205 02 Malmö, SwedenE-mail Malin.Ivarsson@skane.sePreviously published online at DOI: 10.1373/clinchem.2008.116277,;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号